Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ipratropium bromide for symptomatic preterm infants.

B Yuksel1, A Greenough

  • 1Department of Child Health, King's College Hospital, London, United Kingdom.

European Journal of Pediatrics
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of STZ-Induced Diabetes on Zinc, Boron and Antioxidant Defense Mechanisms in Rats.

Nigerian journal of clinical practice·2025
Same author

Comparing the malignant properties of parental and a knock-in version of HCT116 cell line expressing the CDK2-mutant of eukaryotic elongation factor 2 (eEF2).

Molecular biology reports·2025
Same author

Evaluation of Dental Plaque Area with Artificial Intelligence Model.

Nigerian journal of clinical practice·2024
Same author

Prognostic value of Pleth Variability Index in patients followed up in the Intensive Care Unit.

European review for medical and pharmacological sciences·2024
Same author

Different Clinical Effects of Ectodermal Dysplasias in Four Generations.

Actas dermo-sifiliograficas·2023
Same author

Different Clinical Effects of Ectodermal Dysplasias in Four Generations.

Actas dermo-sifiliograficas·2023

Inhaled ipratropium bromide significantly reduced respiratory symptoms and improved lung function in preterm infants with recurrent symptoms. This bronchodilator therapy offers an effective treatment option for these young patients.

Area of Science:

  • Pediatric Pulmonology
  • Neonatology
  • Pharmacology

Background:

  • Preterm infants often experience recurrent respiratory symptoms.
  • Effective treatment options for symptomatic preterm infants are crucial.

Purpose of the Study:

  • To evaluate the efficacy of inhaled ipratropium bromide as a bronchodilator therapy.
  • To assess the impact of ipratropium bromide on respiratory symptoms and lung function in preterm infants.

Main Methods:

  • A randomized, placebo-controlled trial involving twelve preterm infants (median gestational age 31.5 weeks).
  • Infants received either inhaled placebo or ipratropium bromide (40 micrograms) three times daily for 2 weeks, using a coffee cup spacer.
  • Symptom scores and lung function (functional residual capacity) were measured.

Related Experiment Videos

Main Results:

  • A 59% reduction in symptom scores was observed during ipratropium bromide treatment compared to placebo (P < 0.01).
  • Lung function showed a 38% improvement with active therapy versus a 20% change with placebo (P < 0.01).

Conclusions:

  • Inhaled ipratropium bromide is an effective treatment for symptomatic preterm infants.
  • Bronchodilator therapy with ipratropium bromide can alleviate recurrent respiratory symptoms and improve lung function in this population.